eflornithine has been researched along with Epithelial Ovarian Cancer in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"Difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), has promising activity against various cancers and a tolerable safety profile for long-term use as a chemopreventive agent." | 1.62 | Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer. ( Hwang, WY; Kim, K; Kim, YB; No, JH; Park, WH; Suh, DH, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hwang, WY | 1 |
Park, WH | 1 |
Suh, DH | 1 |
Kim, K | 1 |
Kim, YB | 1 |
No, JH | 1 |
1 other study available for eflornithine and Epithelial Ovarian Cancer
Article | Year |
---|---|
Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.
Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Ovarian Epithelial; Caspase 3; Cell Line, Tumor; C | 2021 |